Company news

ProKidney Corp. news in 2024

ProKidney Corp.'s news releases, calls and decks from 2024, newest first.

View company

ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference

November 25, 2024

ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting

November 11, 2024

ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference

November 4, 2024

ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2024

October 13, 2024

ProKidney to Participate in the UBS Virtual Organ Restoration Day

October 8, 2024

ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel’s Registrational Path to Potential Approval in the U.S.

September 2, 2024

ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

August 26, 2024

ProKidney Reports Business Updates and Second Quarter 2024 Financial Results

August 8, 2024

ProKidney Announces the Closing of $140 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering, Including Exercise of Underwriters Option

June 18, 2024

ProKidney Announces the Closing of $140 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering, Including Exercise of Underwriters’ Option

June 16, 2024

ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

June 10, 2024

ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

June 9, 2024

ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates

June 9, 2024

ProKidney to Participate in the Jefferies Global Healthcare Conference

May 28, 2024

ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024

May 20, 2024

ProKidney Reports Business Updates and First Quarter 2024 Financial Results

May 9, 2024

ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations

March 24, 2024

ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights

March 20, 2024

ProKidney to Participate in Jefferies Biotech on the Bay Summit

February 28, 2024

Decks in 2024